Publicaciones (61) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. Acute monocytic leukaemia with histiocytic differentiation and erythrophagocytosis

    Hematology, Transfusion and Cell Therapy, Vol. 45, Núm. 4, pp. 519-520

  2. Analysis of germline variants in pediatric patients diagnosed with desmoid tumors and nuchal-type fibromas

    Translational Pediatrics, Vol. 12, Núm. 9, pp. 1715-1724

  3. Anaplastic morphology in IgD multiple myeloma

    Hematology, Transfusion and Cell Therapy, Vol. 45, Núm. 4, pp. 521-523

  4. Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia

    The Cochrane database of systematic reviews, Vol. 7, pp. CD013511

  5. Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders

    Blood, Vol. 142, Núm. 5, pp. 434-445

  6. Edema lumbar como primera manifestación en púrpura de Schönlein-Henoch

    Boletín de la Sociedad Vasco-Navarra de pediatría = Euskal Herriko Pediatria Elkartearen aldizkaria, Núm. 124, pp. 106-106

  7. Flower-shaped lymphocytes in CD5+ diffuse large B-cell lymphomaÊs leukemic phase

    Blood Research

  8. Genetics and Epigenetics in Complex Diseases

    International Journal of Molecular Sciences

  9. How do hospitalised children die? The context of death and end-of-life decision-making

    Journal of Paediatrics and Child Health, Vol. 59, Núm. 4, pp. 625-630

  10. Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing

    Scientific Reports, Vol. 13, Núm. 1

  11. Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing

    International Journal of Molecular Sciences, Vol. 24, Núm. 22

  12. LncRNA-en adierazpen aldakorrak haurren leuzemia linfoblastiko akutuan dituen inplikazioak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 43, pp. 191-207

  13. Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry

    Breast Cancer Research and Treatment, Vol. 201, Núm. 2, pp. 151-159

  14. Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification

    Acta Neuropathologica, Vol. 145, Núm. 5, pp. 651-666